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Abstract
Background: Depression and anxiety symptoms are commonly experienced by women during the perinatal
period. Changes in sleep and sleep quality are typical throughout pregnancy and early postpartum. However,
little is known about relationships between insomnia symptoms and psychiatric symptoms in perinatal women.
The objective of the present study is to characterize the burden of insomnia symptoms in perinatal women
seeking outpatient psychiatric treatment and to examine relationships between insomnia and symptoms of
depression and anxiety.
Methods: Data from 257 pregnant or postpartum women who sought outpatient psychiatric treatment at a
university hospital-affiliated clinic were extracted from an existing clinical management database. Data included
validated self-report measures assessing insomnia (Insomnia Severity Index [ISI]), mood (Edinburgh Postnatal
Depression Scale [EPDS]), and generalized anxiety (Penn State Worry Questionnaire [PSWQ]).
Results: Fifty-two percent of women reported symptoms of insomnia, 75% reported symptoms of depression,
and 61% reported symptoms of generalized anxiety. After controlling for PSWQ, the partial correlation between
EPDS and ISI was 0.15 and 0.37 for pregnant and postpartum women, respectively. After controlling for EPDS,
the partial correlation between PSWQ and ISI was 0.20 and 0.12 for pregnant and postpartum women, re-
spectively. Women with clinically significant ISI scores had significantly higher odds for reporting symptoms
consistent with depression (odds ratio [OR] 7.7) and generalized anxiety (OR 2.55) compared to women with
lower ISI scores.
Conclusions: Insomnia symptoms affected a significant proportion of the perinatal women in this sample. These
symptoms are linked to symptoms of depression and anxiety in treatment-seeking pregnant and postpartum
women. Perinatal women seen in psychiatric treatment settings should be routinely screened for sleep problems.
Introduction
Depression is experienced by many women duringthe perinatal period and is widely considered to
be the most common and debilitating complication of
childbirth.1,2 Perinatal depression affects 1 in 5 women,
whereas anxiety disorders, although less studied than de-
pression, are estimated to impact asmany as 16% ofwomen in
the early postpartum period.3,4 Impaired maternal function-
ing due to mental illness can affect bonding between mother
and infant and have longer-term consequences for offspring,
including developmental and cognitive impairments,
self-regulation difficulties, low self-esteem, and behavior
problems.5–7
Women experience a myriad of changes during pregnancy
and postpartum that may increase their vulnerability to af-
fective illness, including hormonal fluctuations, increasing
psychosocial demands, and dysregulation of the sleep-wake
cycle. Alterations in sleep patterns are seen as early as the first
trimester, when slow-wave sleep decreases and does not re-
cover until after delivery.8 Total sleep time and sleep effi-
ciency decline throughout pregnancy and reach a nadir
within the first month postpartum.8,9 Sleep disruption and
fragmentation of nighttime sleep are extremely common in
healthy pregnant and postpartum women.8,10 However, the
sleep changes during pregnancy and the sleep deprivation
that is common early in the postpartum period may play a
role in risk for postpartum depression.
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The existing literature has documented associations be-
tween sleep disruptions and mood problems during the
perinatal period. Subjectively reported sleep quality was a
significant predictor of depressive symptoms in postpartum
women at low risk for depression, although a weaker rela-
tionship was found between objective sleep measures and
mood.9 In their study of 124 women from the third trimester
of pregnancy to 3 months postpartum, Goyal et al.11 found
that subjective sleep disturbance was associated with de-
pressive symptoms at the third trimester and at the third
month postpartum, with delayed sleep onset particularly sa-
lient to depressive symptoms. In a prospective study of 273
pregnant women surveyed at three time points from the
second trimester through the third trimester, subjectively re-
ported sleep quality around 18 weeks and 26 weeks of ges-
tation was a significant predictor of depressive symptoms
later in pregnancy; notably, depressive symptoms earlier in
pregnancy were not related to sleep quality at later time
points.12 Similarly, in a Norwegian population-based study
of > 4000 women at 7 weeks postpartum, subjective report of
poor sleep quality was significantly associated with depres-
sion even after controlling for multiple risk factors.13 Poor
sleep quality in the first 17 weeks after delivery increased the
risk for depression recurrence in women who had a past
history of major depressive disorder (MDD) but were not
depressed during pregnancy.14
Most published studies of sleep in perinatal women using
subjective assessments of sleep have focused on sleep quality.
Although it is important to study sleep quality, there are other
aspects of sleep, such as insomnia symptoms, that remain
understudied in perinatal women. (The term ‘‘insomnia
symptoms’’ is used to characterize complaints of sleep dis-
ruption associated with sleep loss but is not diagnostic of
clinical insomnia. Further, the reasons for sleep loss may be
multifactorial in this population, for example, attending to the
infant, physical discomfort, physiological changes, or diffi-
culty falling asleep because of conditioned arousal.) The
perinatal period is rife with factors that disrupt sleep andmay
precipitate and perpetuate insomnia, including the birth of a
child, caregiving demands, napping, and inconsistent sleep-
wake schedules,15,16 yet little is known about the influence of
sleep disruption on mood and functioning around the time of
childbearing. It is important to distinguish between the sleep
disruption experienced by most women during pregnancy
and early postpartum and insomnia. Insomnia is character-
ized by subjectively reported difficulty falling asleep, main-
taining sleep, or poor sleep quality, accompanied by distress
and functional impairments. Given the sleep fragmentation
and chronic sleep loss that most pregnant and postpartum
women experience, they should be able to fall asleep quickly.
Thus, it has been suggested that insomnia in childbearing
women may occur as difficulty falling asleep or returning to
sleep in the absence of physical discomfort or environmental
disturbances (e.g., noise or demands from the infant).17,18
Insomnia has been found to independently increase the risk
for depression and anxiety disorders in nonperinatal popu-
lations.19,20 To date, there are no studies of the relationships
between insomnia symptoms and psychiatric symptoms in
perinatal women who are seeking mental health treatment.
Thus, it remains unknown if insomnia symptoms increase the
risk formental illness or if insomnia symptoms comorbidwith
anxiety and depression worsen the clinical course in perinatal
women. Research clarifying these relationships can inform
interventions targeting sleep disturbance to enhance treat-
ment outcomes.
The aims of the present study are to describe the burden of
insomnia symptoms in perinatal women seeking outpatient
psychiatric treatment and examine associations between in-
somnia symptoms and psychiatric symptoms (i.e., symptoms
of depression and anxiety) in this population. Specifically, we
were interested in whether symptom severity or rates of in-
somnia symptoms differ between pregnant and postpartum
women, which insomnia symptoms best predict depression
and anxiety symptom severity, and if experiencing more se-
vere symptoms of insomnia increases the likelihood of expe-
riencing depression and anxiety symptoms. We hypothesized
that compared to pregnant women, postpartum women
would have higher insomnia symptom severity scores, and
more postpartum women would meet the threshold for clin-
ically significant insomnia symptoms. We also expected that
experiencing significant symptoms of insomnia would be
associated with increased risk for depression and anxiety
symptoms.
Materials and Methods
Participants
Participants were 257 pregnant (n = 114) or postpartum
(n= 143) women who sought evaluation and treatment at a
university hospital-affiliated outpatient psychiatry clinic.
Women were classified as postpartum if they had given birth
in the 6 months prior to their intake visit. Participants ranged
in age from 19 to 51 years of age, with a mean age of 31– 6
years.
Procedures
All patients who come to the clinic for an intake visit
complete assessments of mood and sleep as part of routine
care in the clinic. The data from these assessments are main-
tained in a clinical management database. It is from this
source that we extracted the data for the present study. The
data were de-identified, and the study was granted an ex-
emption from institutional board review by the University of
Michigan Medical Institutional Review Board.
Measures
Participants completed the Insomnia Severity Index (ISI),
the Edinburgh Postnatal Depression Scale (EPDS), and the
Penn State Worry Questionnaire (PSWQ). The ISI is a 7-item
self-report measure of severity of insomnia symptoms over
the past 2 weeks. It has good reliability and validity.21 Scores
on this measure range from 0 to 28. Scores between 0 and 14
indicate mild insomnia symptoms, scores between 15 and 21
indicate insomnia symptoms ofmoderate severity, and scores
‡ 22 indicate severe insomnia symptoms.
The EPDS22 is a valid, reliable 10-item self-report depres-
sion screening questionnaire that screens for depressive
symptoms over the past 7 days in pregnant and postpartum
women. EPDS scores range from 0 to 30, with higher scores
indicating more symptoms of depression. Cox et al.23 suggest
a clinical cutoff of 12 or 13 for significant depressive symp-
toms, which has a sensitivity of 81% and a positive predictive
value of 24% for detecting MDD as diagnosed using Research
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Diagnostic Criteria. Thus, participants scoring > 12 on this
measure were classified as experiencing clinically significant
symptoms of depression.
The PSWQ24 is a 16-item self-report measure designed to
assess worry and symptoms characteristic of generalized
anxiety disorder. It has good validity and reliability.24 Scores
on this measure range from 16 to 80. Participants scoring ‡ 60
on the measure were classified as experiencing generalized
anxiety symptoms.
Statistical analyses
All statistical analyses were performed using SPSS version
17 (SPSS, Inc., Chicago, IL). t Tests with Bonferroni corrections
compared differences in mean scores for the ISI, EPDS, and
PSWQ between pregnant and postpartum women, and chi-
square analyses with Bonferroni corrections tested whether
the proportions of pregnant and postpartum women meeting
the cutoff scores for the ISI, EPDS, and PSWQ were different.
Correlations and partial correlations were computed between
total scores on the ISI, EPDS, and PSWQ. Linear regression
analyses examined the contribution of each ISI item to EPDS
and PSWQ total scores. Odds ratios (ORs) were calculated
using logistic regression to determine if women reporting
moderate or severe symptoms of insomnia were at higher risk
for scoring above cutoffs on the EPDS and PSWQ compared to
women who had subthreshold insomnia symptoms. Regres-
sion analyses were adjusted for maternal age because age was
associated with EPDS and PSWQ scores. Cohen’s d for dif-
ferences in mean ISI score between those women above and
below the clinical thresholds for the EPDS and PSWQwas also
computed. The EPDS contains one item assessing for sleep
problems, and analyses were conducted with and without
that item. No significant difference was observed in the re-
sults, so the results reported here use all EPDS items to cal-
culate total score.
Results
Chronbach alpha values indicated good internal consis-
tency in this sample for all the measures (EPDS = 0.85, ISI =
0.87, PSWQ = 0.95). Mean values and percentage of partici-
pants scoring above the clinical threshold for the ISI, PSWQ,
and EPDS are presented in Table 1 for the total sample and for
the subsamples of pregnant and postpartum women. A sig-
nificant proportion of women scored above the clinical cutoffs
for all the measures. There was a very high incidence of wo-
men meeting the clinical cutoffs for depressive symptoms,
generalized anxiety symptoms, and insomnia symptoms,
particularly among postpartum women. Approximately 12%
of pregnant women and 11% of postpartum women (12% of
the total sample) scored above the threshold for severe in-
somnia. Mean EPDS (t(255) = - 1.60, p = 0.357), PSWQ
(t(254) = - 2.21, p= 0.084), and ISI (t(247)= - 0.56, p = 1.0)
scores were not significantly different between pregnant and
postpartumwomen. Similarly, proportions of women scoring
above the clinical thresholds were not different between
pregnant and postpartumwomen for the EPDS (chi-square (1,
n= 256) = 5.07, p = 0.072), ISI (chi-square (1, n = 249)= 2.76,
p= 0.291), or PSWQ (chi-square (1, n = 256)= 4.11, p = 0.129).
The correlations for the total sample, pregnant women, and
postpartum women are shown in Table 2. The EPDS and
PSWQ correlated significantly with the ISI in the total sample
and in each group separately. As all three measures were
correlated in the total sample and in each group, we also
computed partial correlations to remove the overlapping in-
fluence of EPDS and PSWQ. The resultant partial correlations
are shown in Table 2.
After removing the influence of PSWQ, the correlation be-
tween EPDS and ISI remained significant in postpartum wo-
men but not in pregnant women, indicating that the
relationship between depression symptoms and insomnia
symptoms was significantly influenced by generalized anxi-
ety symptoms, but only in pregnant women. The relationship
between depression symptoms and insomnia symptoms was
not influenced by generalized anxiety symptoms in women in
the postpartum period. However, EPDS also affected the re-
lationship between PSWQ and ISI. Removing its influence
greatly decreased the relationship between generalized anxi-
ety symptoms and insomnia symptoms in both pregnant
and postpartum women, from 25% to 4% of the explained
Table 1. Means and Percentages of Women Above Clinical Threshold for Edinburgh Postnatal Depression
Scale, Penn State Worry Questionnaire, and Insomnia Severity Index
Pregnant n = 114 Postpartum n = 143 Total sample n = 257
Mean – SD % above threshold Mean – SD % above threshold Mean – SD % above threshold
EPDS 15.81– 6.29 68 16.94 – 5.08 80 16.44– 5.67 75
PSWQ 59.35– 19.97 54 64.39 – 16.46 66 62.17– 18.23 61
ISI 14.04– 6.41 45 14.48 – 6.05 55 14.28– 6.21 52
EPDS, Edinburgh Postnatal Depression Scale; ISI, Insomnia Severity Index; PSWQ, Penn State Worry Questionnaire; SD, standard
deviation.
Table 2. Bivariate and Partial Correlations
Among Insomnia Severity Index,
Edinburgh Postnatal Depression Scale,
and Penn State Worry Questionnaire
Total sample
n = 257
Pregnant
n = 114
Postpartum
n = 143
EPDS with PSWQ 0.69*** 0.81*** 0.53***
Controlling for
ISI
0.63*** 0.78*** 0.46***
EPDS with ISI 0.49*** 0.50*** 0.48***
Controlling for
PSWQ
0.29*** 0.15 0.37***
PSWQ with ISI 0.43*** 0.51*** 0.53***
Controlling for
EPDS
0.14* 0.20* 0.12
*p< 0.05; ***p £ 0.001.
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variance. Thus, the interrelationship among depression, in-
somnia, and generalized anxiety symptoms differed between
pregnant and postpartum women.
To determine which specific insomnia symptoms were
cross-sectional predictors of EPDS and PSWQ total score,
linear regressions were computed, removing the influence of
maternal age first. These results are shown in Tables 3 and 4
for the EPDS and PSWQ, respectively. Only one ISI item, as-
sessing difficulty falling asleep, was found to be a significant
predictor of EPDS and PSWQ scores, and it wasmore strongly
predictive of EPDS score.
Logistic regression assessed if scoring above the moderate
and severe ISI cutoffs was associated with increased risk for
scoring above the EPDS and PSWQ thresholds. Women who
scored above the threshold for moderate insomnia symptoms
had significantly greater ORs for reporting significant depres-
sion symptoms (OR 7.7, confidence interval [CI] 3.76-15.78,
p< 0.001) and reporting symptoms of generalized anxiety (OR
2.55, CI 1.39-4.69, p= 0.003) compared to those women who
scored below the ISI cutoff. TheORs for reporting symptoms of
depression (OR 11.11, CI 1.48-83.37, p= 0.019) and generalized
anxiety symptoms (OR 3.59, CI 1.32-9.79, p= 0.012) also were
significantly greater for women who scored above the thresh-
old for severe insomnia symptoms.
The effect size for the difference in insomnia symptoms
between women who scored above the EPDS and PSWQwas
also computed using Cohen’s d. These results are shown in
Table 5. There was a large effect for insomnia symptoms on
depressive symptoms and a moderate effect on generalized
anxiety symptoms.
Discussion
More than half of the participants in this sample of 257
perinatal womenwho sought psychiatry outpatient treatment
reported moderately severe insomnia symptoms, and 12%
reported severe insomnia symptoms. As expected in this
population, clinically significant depression symptoms were
present in 75% of the participants, and 61% had clinically
significant generalized anxiety symptoms. Mean scores and
proportions of women scoring above the clinical threshold on
the measures were comparable between pregnant and post-
partum women.
In this relatively large sample of treatment-seeking peri-
natal women, insomnia symptoms were linked to depression
and generalized anxiety symptoms. However, the relation-
ships among insomnia symptoms, depression symptoms, and
generalized anxiety symptoms are not straightforward and in
this sample relate to whether or not the woman is pregnant or
postpartum. Specifically, among pregnant women, there was
no relationship between depression symptoms and insomnia
symptoms when controlling for the variance associated with
generalized anxiety symptoms. Among postpartum women,
this relationship remained even after controlling for general-
ized anxiety symptoms. Alternatively, the relationship be-
tween generalized anxiety symptoms and insomnia
symptoms, when controlling for depression symptoms, was
small but significant for pregnant women but not for post-
partum women. There was no relationship between general-
ized anxiety symptoms and insomnia symptoms for
postpartum women when controlling for depression symp-
toms. The results suggest that although there is shared vari-
ance for depression and generalized anxiety symptoms in
relation to insomnia symptoms, the unique contribution of the
two symptom clusters is different for pregnant and postpar-
tum women. Therefore, these symptom clusters may be con-
tributing to insomnia symptoms in different ways. It appears
that for pregnant women, anxiety symptoms are the larger
contributor to insomnia symptoms; whereas for postpartum
women, depression symptoms are the larger contributor.
Women who had moderate symptoms of insomnia had
7-fold greater odds of scoring above the threshold for de-
pressive symptoms and 2-fold greater odds of scoring above
the threshold for generalized anxiety symptoms. These ORs are
similar to those found in a population-based study of post-
partum women examining sleep quality and depression.13
Table 3. Insomnia Severity Index Items as Predictors
of Edinburgh Postnatal Depression Scale
Total Score
B SE B b p
Maternal age - 0.09 0.06 - 0.09 0.076
Difficulty falling asleep 1.36 0.35 0.28 < 0.001
Difficulty staying asleep 0.35 0.39 0.07 0.383
Problem waking too early 0.35 0.30 0.08 0.245
Dissatisfaction with sleep pattern - 0.53 0.47 - 0.09 0.253
Daytime functioning impaired 0.27 0.43 0.06 0.539
Impairment noticeable to others 0.67 0.35 0.15 0.056
Distress about sleep problem 0.55 0.41 0.12 0.187
B, unstandardized coefficient; SE B, standard error of unstandar-
dized coefficient.
Table 4. Insomnia Severity Index Items
as Predictors of Penn State
Worry Questionnaire Total Score
B SE B b p
Maternal age - 0.302 0.19 - 0.09 0.105
Difficulty falling asleep 2.56 1.18 0.17 0.031
Difficulty staying asleep 0.63 1.32 0.04 0.635
Problem waking too early 1.29 1.00 0.09 0.197
Dissatisfaction with sleep pattern 0.64 1.55 0.03 0.680
Daytime functioning impaired 0.79 1.44 0.05 0.582
Impairment noticeable to others 1.32 1.16 0.09 0.255
Distress about sleep problem 1.40 1.38 0.09 0.309
Table 5. Comparison of Mean Insomnia Severity Index
Scores for Women Above and Below Edinburgh
Postnatal Depression Scale and Penn State
Worry Questionnaire Thresholds
EPDS < 14
n = 61
EPDS ‡ 14
n = 187 t Cohen’s d
ISI score
mean– SD
9.49 – 4.97 15.86 – 5.77 - 7.73 1.14
PSWQ < 60
n = 96
PSWQ ‡ 60
n = 153 t Cohen’s d
ISI score
mean– SD
11.67– 5.95 15.92 – 5.81 - 5.58 0.72
All p£ 0.001.
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ORs for experiencing depression symptomswere even greater
among women who reported severe insomnia symptoms
(11-fold); however, ORs for experiencing generalized anxiety
symptoms were comparable relative to women who reported
moderate insomnia symptoms. This suggests that although
generalized anxiety symptoms do not change with insomnia
symptom severity, depression symptoms are significantly
influenced by insomnia symptom severity.
Correspondingly, large and moderate effects were found
for insomnia symptoms between women scoring above and
below the EPDS and PSWQ thresholds, respectively.
Although ISI total score was clearly related to both depression
and anxiety measures, when examining the contribution of
each item to these measures, only difficulty falling asleep was
a significant predictor of depression and anxiety scores. This
finding is consistent with Goyal et al.’s results, which showed
that delayed sleep onset was most strongly associated with
depressive symptoms.11
There are several limitations of this study that warrant
discussion. The only demographic variable available in our
dataset was maternal age. It is likely that other demographic
variables and psychosocial factors, such as parity, socioeco-
nomic status, marital or partnered status, psychiatric history,
and social support, influence the relationship between sleep
and mood. Our methods of characterizing insomnia, depres-
sion, and generalized anxiety symptoms, although practical
for a large sample, have limitations. The ISI and PSWQ have
not been validated in childbearing samples, and the PSWQ
only measures symptoms of generalized anxiety, which may
limit the generalizability of the findings to other anxiety
symptoms. Clinician-rated assessments of mood and objec-
tive measures of sleep would allow more comprehensive
characterization of psychiatric symptoms and sleep patterns.
Lack of information about history of sleep problems and if
external causes (e.g., caring for an infant, physical discomfort)
produced the sleep difficulties is also a limitation. Our sample
consisted of treatment-seeking perinatal women, and these
results may not generalize to perinatal women who are not at
risk for mental health problems. Finally, the cross-sectional
design does not allow for conclusions about causality.
Conclusions
The findings from this study have significant implications
for clinical practice. Considering that more than half of the
perinatal women who came for psychiatric outpatient treat-
ment reported clinically significant symptoms of insomnia, all
perinatal women seen in these settings should be routinely
assessed for sleep problems. There are few self-report sleep
measures that are validated for use in perinatal women, and
validation of the ISI in childbearing women is important.
Modifying the ISI so that only those sleep disturbances most
likely to represent insomnia (e.g., instructing women to in-
dicate whether they experience these symptoms unrelated to
infant care or environmental disturbance) would better tailor
the measure to this population.
Our results suggest that asking just one sleep-related
question (e.g., about difficulty falling asleep) may help iden-
tify women who are at risk for experiencing significant mood
problems related to insomnia. The optimal treatment ap-
proach for sleep disturbance may vary depending on whether
the woman is pregnant or postpartum. In our sample, anxiety
was a strong contributor to the relationship between mood
and insomnia for pregnant but not postpartum women.
Therefore, treatment of anxiety in pregnant women who
are reporting insomnia may lead to sleep improvements. In-
terventions targeting insomnia are critical for this popula-
tion, although more research is needed to determine if sleep
interventions in this population cause improvements in
symptoms of depression and anxiety. Studies using longitu-
dinal methodologies (e.g., following women from before
conception through the first 6 months postpartum) will be
essential to fully appreciate the nature of the relationships
between sleep and mental health around the time of child-
bearing.
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